Chlorpheniramine
(DBAKFASWICGISY-BTJKTKAUSA-N)
Structure
- SMILES
- CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C.OC(=O)/C=C\C(=O)O
- Molecular Formula:
- C20H23ClN2O4
- Molecular Weight:
- 390.861
- Log P:
- 3.5304
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 2
- TPSA:
- 90.73
- CAS Number(s):
- 113-92-8; 132-22-9
Synonym(s)
1.
Chlorpheniramine
2.
Chlorphenamine
3.
Chlorprophenpyridamine
4.
Aller-Chlor
5.
Antihistaminico Llorens
6.
Chlo-Amine
7.
Chlor-100
8.
Chlor-Trimeton
9.
Chlor-Tripolon
10.
Chlorpheniramine Maleate
11.
Chlorpheniramine Tannate
12.
Chlorpro
13.
Chlorspan 12
14.
Chlortab-4
15.
Cloro-Trimeton
16.
Efidac 24
17.
Kloromin
18.
Piriton
19.
Teldrin
20.
Maleate, Chlorpheniramine
21.
Tannate, Chlorpheniramine
External Link(s)
| MeSH | D002744 |
| PubChem Compound | 5281068 5284366 |
| BindingDB | 50367333 |
| ChEBI | 3645 |
| CHEMBL | CHEMBL1659 |
| KEGG | cpd:C07780 dr:D00665 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Product use issue | FAERS: 12 | US FAERS | |
| 2 | Benign Prostatic Hyperplasia | FAERS: 10 | US FAERS | |
| 3 | Expired product administered | FAERS: 6 | US FAERS | |
| 4 | Therapeutic response unexpected | FAERS: 6 | US FAERS | |
| 5 | Diabetes Mellitus | FAERS: 4 | US FAERS | |
| 6 | Drug administration error | FAERS: 4 | US FAERS | |
| 7 | Drug level below therapeutic | FAERS: 4 | US FAERS | |
| 8 | Drug toxicity | FAERS: 4 | US FAERS | |
| 9 | Peptic Ulcer | FAERS: 4 | US FAERS | |
| 10 | Somnolence | FAERS: 4 | US FAERS | |
| 11 | Anaphylactic shock | FAERS: 3 | US FAERS | |
| 12 | Cerebrovascular accident | FAERS: 3 | US FAERS | |
| 13 | Circumstance or information capable of leading to medication error | FAERS: 3 | US FAERS | |
| 14 | Drug ineffective | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Product use in unapproved indication | FAERS: 3 | US FAERS | |
| 16 | Vertigo | FAERS: 3 | US FAERS | |
| 17 | Blood alcohol | FAERS: 2 | US FAERS | |
| 18 | Choking | FAERS: 2 | US FAERS | |
| 19 | Drug Dependence | FAERS: 2 | US FAERS | |
| 20 | Drug exposure during pregnancy | FAERS: 2 | US FAERS | |
| 21 | Epistaxis | FAERS: 2 | US FAERS | |
| 22 | Fatigue | FAERS: 2 | US FAERS | |
| 23 | Malaise | FAERS: 2 | US FAERS | |
| 24 | Nephrolithiasis | FAERS: 2 | US FAERS | |
| 25 | Pallor | FAERS: 2 | US FAERS | |
| 26 | Palpitations | FAERS: 2 | US FAERS | |
| 27 | Restlessness | FAERS: 2 | US FAERS | |
| 28 | Stillbirth | FAERS: 2 | US FAERS | |
| 29 | Ageusia | FAERS: 1 | US FAERS | |
| 30 | Agitation | FAERS: 1 | US FAERS | |
| 31 | Bipolar Disorder | FAERS: 1 | US FAERS | |
| 32 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 33 | Dizziness | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 34 | Drug Tolerance | FAERS: 1 | US FAERS | |
| 35 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 36 | Drug withdrawal syndrome | FAERS: 1 | US FAERS | |
| 37 | Dry skin | FAERS: 1 | US FAERS | |
| 38 | Euphoric mood | FAERS: 1 | US FAERS | |
| 39 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 40 | Headache | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 41 | Inappropriate affect | FAERS: 1 | US FAERS | |
| 42 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 43 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 44 | Intercepted drug administration error | FAERS: 1 | US FAERS | |
| 45 | Locked-In Syndrome | FAERS: 1 | US FAERS | |
| 46 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 47 | Nausea | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 48 | Nervousness | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 49 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 50 | Overdose | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 51 | Pain | FAERS: 1 | US FAERS | |
| 52 | Product prescribing issue | FAERS: 1 | US FAERS | |
| 53 | Quadruple vessel bypass graft | FAERS: 1 | US FAERS | |
| 54 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 55 | Swelling | FAERS: 1 | US FAERS | |
| 56 | Syncope | FAERS: 1 | US FAERS | |
| 57 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 58 | Tremor | FAERS: 1 | US FAERS | |
| 59 | Vomiting | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 60 | Walking aid user | FAERS: 1 | US FAERS | |
| 61 | Wrong drug administered | FAERS: 1 | US FAERS | |
| 62 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 63 | nervous system disorder | FAERS: 1 | US FAERS | |
| 64 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 65 | Angioedema | Canada Vigilance: 1 | Canada Vigilance | |
| 66 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 67 | Chest discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 68 | Chills | Canada Vigilance: 1 | Canada Vigilance | |
| 69 | Hypersensitivity | Canada Vigilance: 1 | Canada Vigilance | |
| 70 | Injection site inflammation | Canada Vigilance: 1 | Canada Vigilance | |
| 71 | Mental impairment | Canada Vigilance: 1 | Canada Vigilance | |
| 72 | Tachycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 73 | Tinnitus | Canada Vigilance: 2 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.